These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28668678)

  • 1. Moxifloxacin plus rifampin as an alternative for levofloxacin plus rifampin in the treatment of a prosthetic joint infection with Staphylococcus aureus.
    Wouthuyzen-Bakker M; Tornero E; Morata L; Nannan Panday PV; Jutte PC; Bori G; Kampinga GA; Soriano A
    Int J Antimicrob Agents; 2018 Jan; 51(1):38-42. PubMed ID: 28668678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of antibiotic treatment of implant-associated
    Greimel F; Scheuerer C; Gessner A; Simon M; Kalteis T; Grifka J; Benditz A; Springorum HR; Schaumburger J
    Drug Des Devel Ther; 2017; 11():1729-1736. PubMed ID: 28652709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal activity of the combination of levofloxacin with rifampin in experimental prosthetic knee infection in rabbits due to methicillin-susceptible Staphylococcus aureus.
    Muller-Serieys C; Saleh Mghir A; Massias L; Fantin B
    Antimicrob Agents Chemother; 2009 May; 53(5):2145-8. PubMed ID: 19273687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention.
    Lora-Tamayo J; Murillo O; Iribarren JA; Soriano A; Sánchez-Somolinos M; Baraia-Etxaburu JM; Rico A; Palomino J; Rodríguez-Pardo D; Horcajada JP; Benito N; Bahamonde A; Granados A; del Toro MD; Cobo J; Riera M; Ramos A; Jover-Sáenz A; Ariza J;
    Clin Infect Dis; 2013 Jan; 56(2):182-94. PubMed ID: 22942204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococcus lugdunensis, a serious pathogen in periprosthetic joint infections: comparison to Staphylococcus aureus and Staphylococcus epidermidis.
    Lourtet-Hascoët J; Bicart-See A; Félicé MP; Giordano G; Bonnet E
    Int J Infect Dis; 2016 Oct; 51():56-61. PubMed ID: 27609028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
    Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
    Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraosteoblastic activity of levofloxacin and rifampin alone and in combination against clinical isolates of meticillin-susceptible Staphylococcus aureus causing prosthetic joint infection.
    Meléndez-Carmona MÁ; Muñoz-Gallego I; Viedma E; Lora-Tamayo J; Chaves F
    Int J Antimicrob Agents; 2019 Sep; 54(3):356-360. PubMed ID: 31254616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prosthetic joint infections due to Staphylococcus aureus and coagulase-negative staphylococci.
    Tornero E; García-Oltra E; García-Ramiro S; Martínez-Pastor JC; Bosch J; Climent C; Morata L; Camacho P; Mensa J; Soriano A
    Int J Artif Organs; 2012 Oct; 35(10):884-92. PubMed ID: 23138701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones.
    Dalhoff A; Schubert S
    Int J Antimicrob Agents; 2010 Sep; 36(3):216-21. PubMed ID: 20630710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levofloxacin plus rifampicin conservative treatment of 25 early staphylococcal infections of osteosynthetic devices for rigid internal fixation.
    Barberán J; Aguilar L; Giménez MJ; Carroquino G; Granizo JJ; Prieto J
    Int J Antimicrob Agents; 2008 Aug; 32(2):154-7. PubMed ID: 18571387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus.
    Senneville E; Joulie D; Legout L; Valette M; Dezèque H; Beltrand E; Roselé B; d'Escrivan T; Loïez C; Caillaux M; Yazdanpanah Y; Maynou C; Migaud H
    Clin Infect Dis; 2011 Aug; 53(4):334-40. PubMed ID: 21810745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study.
    Leijtens B; Elbers JBW; Sturm PD; Kullberg BJ; Schreurs BW
    BMC Infect Dis; 2017 May; 17(1):321. PubMed ID: 28464821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzalkonium chloride enhances antibacterial activity of gatifloxacin and reduces its propensity to select for fluoroquinolone-resistant strains.
    Hesje CK; Borsos SD; Blondeau JM
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):329-34. PubMed ID: 19650708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-compliance with IDSA guidelines for patients presenting with methicillin-susceptible Staphylococcus aureus prosthetic joint infection is a risk factor for treatment failure.
    Bouaziz A; Uçkay I; Lustig S; Boibieux A; Lew D; Hoffmeyer P; Neyret P; Chidiac C; Ferry T
    Med Mal Infect; 2018 May; 48(3):207-211. PubMed ID: 29122410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prosthetic joint infections due to methicillin-resistant and methicillin-susceptible staphylococci treated with open debridement and retention of the prosthesis.
    Tornero E; Morata L; Martínez-Pastor JC; Bori G; Mensa J; Soriano A
    Rev Esp Quimioter; 2013 Dec; 26(4):353-9. PubMed ID: 24399349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models.
    Patel MV; De Souza NJ; Gupte SV; Jafri MA; Bhagwat SS; Chugh Y; Khorakiwala HF; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4754-61. PubMed ID: 15561853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcus aureus versus Staphylococcus epidermidis in periprosthetic joint infection-Outcome analysis of methicillin-resistant versus methicillin-susceptible strains.
    Hischebeth GT; Randau TM; Ploeger MM; Friedrich MJ; Kaup E; Jacobs C; Molitor E; Hoerauf A; Gravius S; Wimmer MD
    Diagn Microbiol Infect Dis; 2019 Feb; 93(2):125-130. PubMed ID: 30266398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daptomycin combinations as alternative therapies in experimental foreign-body infection caused by meticillin-susceptible Staphylococcus aureus.
    El Haj C; Murillo O; Ribera A; Vivas M; Garcia-Somoza D; Tubau F; Cabellos C; Cabo J; Ariza J
    Int J Antimicrob Agents; 2015 Aug; 46(2):189-95. PubMed ID: 26051988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Therapy, Microbiological Findings, and Comorbidity Influence the Outcome of Prosthetic Joint Infections Undergoing 2-Stage Exchange.
    Ascione T; Pagliano P; Balato G; Mariconda M; Rotondo R; Esposito S
    J Arthroplasty; 2017 Jul; 32(7):2239-2243. PubMed ID: 28372916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapy.
    Peel TN; Buising KL; Dowsey MM; Aboltins CA; Daffy JR; Stanley PA; Choong PF
    Antimicrob Agents Chemother; 2013 Jan; 57(1):350-5. PubMed ID: 23114758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.